Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 2, p. 98, doi. 10.1177/1753944716636042
- By:
- Publication type:
- Article
Works matching IS 17539447 AND DT 2016 AND VI 10 AND IP 2
Results: 6
1
2
Potential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspectives.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 2, p. 103, doi. 10.1177/1753944716630694
- By:
- Publication type:
- Article
3
Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 2, p. 56, doi. 10.1177/1753944715624854
- By:
- Publication type:
- Article
4
The potential cost-effectiveness of the Diamondback 360® Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approach.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 2, p. 74, doi. 10.1177/1753944715622145
- By:
- Publication type:
- Article
5
Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 2, p. 86, doi. 10.1177/1753944715622120
- By:
- Publication type:
- Article
6
Assessment of blood pressure in patients with hypertension aged 60–79 years before and after the publication of the 2014 Eighth Joint National Committee report.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 2, p. 67, doi. 10.1177/1753944715621000
- By:
- Publication type:
- Article